Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors

Por Dolly, Saoirse O., Wagner, Andrew J., Bendell, Johanna C., Kindler, Hedy L., Krug, Lee M., Seiwert, Tanguy Y., Zauderer, Marjorie G., Lolkema, Martijn P., Apt, Doris, Yeh, Ru-Fang, Fredrickson, Jill O., Spoerke, Jill M., Koeppen, Hartmut, Ware, Joseph A., Lauchle, Jennifer O., Burris, Howard A., de Bono, Johann S.
Publicado no Clin Cancer Res (2016)